Similar articles for PMID: 28392860

Year	Number of Results
1990	1
1996	1
1997	1
1998	1
1999	1
2002	2
2003	2
2004	1
2005	2
2006	1
2007	1
2008	3
2010	1
2011	1
2012	2
2013	7
2014	6
2015	5
2016	11
2017	11
2018	7
2019	4
2021	2
2024	0

1

The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study.

Kakuda H, Kobayashi J, Sakurai M, Kakuda M, Takekoshi N. Kakuda H, et al. J Clin Med Res. 2017 May;9(5):403-409. doi: 10.14740/jocmr2806w. Epub 2017 Apr 1. J Clin Med Res. 2017. PMID: 28392860 Free PMC article.

2

Residual Effect of Sodium Glucose Cotransporter 2 Inhibitor, Tofogliflozin, on Body Weight After Washout in Japanese Men With Type 2 Diabetes.

Kakuda H, Kobayashi J, Sakurai M, Takekoshi N. Kakuda H, et al. J Clin Med Res. 2019 Jan;11(1):35-41. doi: 10.14740/jocmr3650. Epub 2018 Dec 3. J Clin Med Res. 2019. PMID: 30627276 Free PMC article.

3

Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study.

Bekki M, Tahara N, Tahara A, Igata S, Honda A, Sugiyama Y, Nakamura T, Sun J, Kumashiro Y, Matsui T, Fukumoto Y, Yamagishi SI. Bekki M, et al. Curr Vasc Pharmacol. 2019;17(4):411-420. doi: 10.2174/1570161116666180515154555. Curr Vasc Pharmacol. 2019. PMID: 29766812 Clinical Trial.

4

Comparison of Combined Tofogliflozin and Glargine, Tofogliflozin Added to Insulin, and Insulin Dose-Increase Therapy in Uncontrolled Type 2 Diabetes.

Suzuki K, Mitsuma Y, Sato T, Anraku T, Hatta M. Suzuki K, et al. J Clin Med Res. 2016 Nov;8(11):805-814. doi: 10.14740/jocmr2741w. Epub 2016 Sep 29. J Clin Med Res. 2016. PMID: 27738482 Free PMC article.

5

Efficacy and Safety of Tofogliflozin on 24-h Glucose Profile Based on Continuous Glucose Monitoring: Crossover Study of Sodium-Glucose Cotransporter 2 Inhibitor.

Kurozumi A, Okada Y, Shimokawa M, Goshima Y, Otsuka T, Narisawa M, Torimoto K, Tanaka Y. Kurozumi A, et al. Diabetes Technol Ther. 2019 Jul;21(7):385-392. doi: 10.1089/dia.2019.0099. Epub 2019 Jun 17. Diabetes Technol Ther. 2019. PMID: 31210529 Clinical Trial.

6

Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.

Sawada T, Tsubata H, Hashimoto N, Takabe M, Miyata T, Aoki K, Yamashita S, Oishi S, Osue T, Yokoi K, Tsukishiro Y, Onishi T, Shimane A, Taniguchi Y, Yasaka Y, Ohara T, Kawai H, Yokoyama M. Sawada T, et al. Cardiovasc Diabetol. 2016 Aug 26;15(1):121. doi: 10.1186/s12933-016-0437-y. Cardiovasc Diabetol. 2016. PMID: 27565734 Free PMC article.

7

Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models.

Suzuki M, Takeda M, Kito A, Fukazawa M, Yata T, Yamamoto M, Nagata T, Fukuzawa T, Yamane M, Honda K, Suzuki Y, Kawabe Y. Suzuki M, et al. Nutr Diabetes. 2014 Jul 7;4(7):e125. doi: 10.1038/nutd.2014.20. Nutr Diabetes. 2014. PMID: 25000147 Free PMC article.

8

Evaluation of metabolic parameters and body composition in Japanese patients with type 2 diabetes mellitus who were administered tofogliflozin for 48 weeks.

Iwahashi Y, Hirose S, Nakajima S, Seo A, Takahashi T, Tamori Y. Iwahashi Y, et al. Diabetol Int. 2016 Nov 11;8(2):205-211. doi: 10.1007/s13340-016-0295-6. eCollection 2017 Jun. Diabetol Int. 2016. PMID: 30603323 Free PMC article.

9

Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA. Lund SS, et al. Eur J Endocrinol. 2008 Jan;158(1):35-46. doi: 10.1530/EJE-07-0500. Eur J Endocrinol. 2008. PMID: 18166815 Clinical Trial.

10

Short-term effect of pitavastatin treatment on glucose and lipid metabolism and oxidative stress in fasting and postprandial state using a test meal in Japanese men.

Kakuda H, Kobayashi J, Nakato M, Takekoshi N. Kakuda H, et al. Cholesterol. 2013;2013:314170. doi: 10.1155/2013/314170. Epub 2013 Dec 10. Cholesterol. 2013. PMID: 24386561 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

63 results

Results by year